Know Cancer

or
forgot password

A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial


N/A
18 Years
70 Years
Not Enrolling
Both
Gastric Cancer

Thank you

Trial Information

A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial


Inclusion Criteria:

Patients with biopsy/frozen section proven adenocarcinoma of stomach.

- Preoperative clinical examination and imaging indicating operable disease.

- Intraoperative exploration indicating operability i.e. no peritoneal deposits,no
evidence of para aortic lymphadenopathy,no direct involvement of contiguous organs

- Surgical plan for distal/proximal/total gastrectomy

Exclusion Criteria:Patients with low performance score

- Staging investigations or intraoperative exploration indicating inoperable disease

- Patients medically unfit for major surgery

- Patients who have been given preoperative chemotherapy/chemoradiation.

- Patients with gastroesophageal junction tumours

- Patients unreliable for follow up

- Patients above the age of 70 years

- Past history of malignancy

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

5 year overall survival

Principal Investigator

Dr Parul J Shukla, M.S.,FRCS

Investigator Role:

Principal Investigator

Investigator Affiliation:

Tata Memorial Centre,Mumbai

Authority:

Hospital Scientific Committee,Tata Memorial Centre Mumbai,India:

Study ID:

TMH 262

NCT ID:

NCT00447746

Start Date:

March 2007

Completion Date:

March 2014

Related Keywords:

  • Gastric Cancer
  • Comparison between D1 and D2 lymphadenectomy for gastric cancer
  • Stomach Neoplasms

Name

Location